{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:05:28Z","timestamp":1791821128677,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T00:00:00Z","timestamp":1421366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"funder":[{"name":"Norwegian ExtraFoundation for Health and Rehabilitation","award":["2008-2-0159"],"award-info":[{"award-number":["2008-2-0159"]}]},{"name":"The North Norway Regional Health Authority","award":["SFP890-09"],"award-info":[{"award-number":["SFP890-09"]}]},{"name":"Blakstad and Maarschalk Tuberkulosefond"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jinf.2014.12.019","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T20:11:27Z","timestamp":1421352687000},"page":"381-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy"],"prefix":"10.1016","volume":"70","author":[{"given":"I.","family":"Wergeland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Pullar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Assmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tonby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Feruglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kvale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.K.","family":"Dam\u00e5s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.E.","family":"Mollnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Dyrhol-Riise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2014.12.019_bib1","series-title":"Global tuberculosis report","author":"World Health Organization","year":"2014"},{"issue":"9","key":"10.1016\/j.jinf.2014.12.019_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection","volume":"320","author":"Selwyn","year":"1989","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jinf.2014.12.019_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"3\u20134","key":"10.1016\/j.jinf.2014.12.019_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drudis.2009.10.005","article-title":"The quest for biomarkers in tuberculosis","volume":"15","author":"Parida","year":"2010","journal-title":"Drug Discov Today"},{"issue":"5","key":"10.1016\/j.jinf.2014.12.019_bib5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.clinthera.2012.03.006","article-title":"Utility of interferon-gamma release assay results to monitor anti-tubercular treatment in adults and children","volume":"34","author":"Chiappini","year":"2012","journal-title":"Clin Ther"},{"issue":"9","key":"10.1016\/j.jinf.2014.12.019_bib6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-144-9-200605020-00008","article-title":"Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome","volume":"144","author":"Holtz","year":"2006","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jinf.2014.12.019_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(10)70003-7","article-title":"Biomarkers for tuberculosis disease activity, cure, and relapse","volume":"10","author":"Wallis","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"9332","key":"10.1016\/j.jinf.2014.12.019_bib8","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(02)09742-8","article-title":"Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial","volume":"360","author":"Benator","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jinf.2014.12.019_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1164\/rccm.200904-0536OC","article-title":"Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion","volume":"180","author":"Johnson","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.jinf.2014.12.019_bib10","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1469-0691.2009.03104.x","article-title":"Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls","volume":"16","author":"Biselli","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2014.12.019_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2466-9-21","article-title":"Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report","volume":"9","author":"Chegou","year":"2009","journal-title":"BMC Pulm Med"},{"issue":"5","key":"10.1016\/j.jinf.2014.12.019_bib12","doi-asserted-by":"crossref","first-page":"e64226","DOI":"10.1371\/journal.pone.0064226","article-title":"Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting","volume":"8","author":"Chegou","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jinf.2014.12.019_bib13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tube.2011.02.006","article-title":"Discriminating between latent and active tuberculosis with multiple biomarker responses","volume":"91","author":"Frahm","year":"2011","journal-title":"Tuberculosis (Edinb )"},{"issue":"4","key":"10.1016\/j.jinf.2014.12.019_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jinf.2012.11.005","article-title":"Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection","volume":"66","author":"Mihret","year":"2013","journal-title":"J Infect"},{"issue":"8","key":"10.1016\/j.jinf.2014.12.019_bib15","doi-asserted-by":"crossref","first-page":"e12365","DOI":"10.1371\/journal.pone.0012365","article-title":"Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort","volume":"5","author":"Sutherland","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jinf.2014.12.019_bib16","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1183\/09031936.00151413","article-title":"Beyond the IFN-gamma horizon: biomarkers for immunodiagnosis of infection with M. tuberculosis","volume":"43","author":"Chegou","year":"2014","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jinf.2014.12.019_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/erm.11.97","article-title":"IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions","volume":"12","author":"Ruhwald","year":"2012","journal-title":"Expert Rev Mol Diagn"},{"issue":"9","key":"10.1016\/j.jinf.2014.12.019_bib18","doi-asserted-by":"crossref","first-page":"e12577","DOI":"10.1371\/journal.pone.0012577","article-title":"Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?","volume":"5","author":"Goletti","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jinf.2014.12.019_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAD.0b013e328334895e","article-title":"Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients","volume":"24","author":"Kabeer","year":"2010","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jinf.2014.12.019_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jinf.2012.03.017","article-title":"IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country","volume":"65","author":"Vanini","year":"2012","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.jinf.2014.12.019_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/00365548.2011.632644","article-title":"Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study","volume":"44","author":"Alsleben","year":"2012","journal-title":"Scand J Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2014.12.019_bib22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jinf.2014.06.013","article-title":"IP-10 is an accurate biomarker for the diagnosis of tuberculosis in children","volume":"69","author":"Latorre","year":"2014","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.jinf.2014.12.019_bib23","first-page":"731","article-title":"Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children","volume":"13","author":"Lighter","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"10.1016\/j.jinf.2014.12.019_bib24","doi-asserted-by":"crossref","first-page":"e2858","DOI":"10.1371\/journal.pone.0002858","article-title":"Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10","volume":"3","author":"Ruhwald","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jinf.2014.12.019_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2004.09.004","article-title":"IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection","volume":"7","author":"Azzurri","year":"2005","journal-title":"Microbes Infect"},{"issue":"3","key":"10.1016\/j.jinf.2014.12.019_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jinf.2013.09.033","article-title":"Efficacy of IP-10 as a biomarker for monitoring tuberculosis treatment","volume":"68","author":"Hong","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2014.12.019_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2334-14-125","article-title":"Impact of HIV co-infection on plasma level of cytokines and chemokines of pulmonary tuberculosis patients","volume":"14","author":"Mihret","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2014.12.019_bib28","doi-asserted-by":"crossref","first-page":"e36886","DOI":"10.1371\/journal.pone.0036886","article-title":"Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis","volume":"7","author":"Riou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2014.12.019_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2334-11-135","article-title":"IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy","volume":"11","author":"Kabeer","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2014.12.019_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2334-10-57","article-title":"Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country","volume":"10","author":"Dyrhol-Riise","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2014.12.019_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5588\/ijtld.13.0276","article-title":"Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway","volume":"18","author":"Pullar","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jinf.2014.12.019_bib32","article-title":"Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection","author":"Feruglio","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2014.12.019_bib33","series-title":"Tuberkuloseveilederen (Norwegian, Guidelines for tuberculosis)","author":"Nasjonalt folkehelseinstitutt","year":"2014"},{"issue":"1","key":"10.1016\/j.jinf.2014.12.019_bib34","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4049\/jimmunol.182.1.588","article-title":"IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients","volume":"182","author":"Sandanger","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2014.12.019_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0974-2700.58666","article-title":"A biomarker panel to discriminate between systemic inflammatory response syndrome and sepsis and sepsis severity","volume":"3","author":"Punyadeera","year":"2010","journal-title":"J Emerg Trauma Shock"},{"issue":"5","key":"10.1016\/j.jinf.2014.12.019_bib36","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/hep.23509","article-title":"Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C","volume":"51","author":"Askarieh","year":"2010","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.jinf.2014.12.019_bib37","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/QAD.0b013e3283489d1f","article-title":"The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women","volume":"25","author":"Keating","year":"2011","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.jinf.2014.12.019_bib38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2249.2000.01144.x","article-title":"Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection","volume":"119","author":"Stylianou","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.jinf.2014.12.019_bib39","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1128\/IAI.67.8.4295-4297.1999","article-title":"Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan","volume":"67","author":"Juffermans","year":"1999","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.jinf.2014.12.019_bib40","doi-asserted-by":"crossref","first-page":"e46143","DOI":"10.1371\/journal.pone.0046143","article-title":"Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection","volume":"7","author":"Liovat","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jinf.2014.12.019_bib41","doi-asserted-by":"crossref","first-page":"e855","DOI":"10.1016\/j.ijid.2012.07.013","article-title":"Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis","volume":"16","author":"Hong","year":"2012","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2014.12.019_bib42","first-page":"192","article-title":"Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis","volume":"15","author":"Chen","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"10.1016\/j.jinf.2014.12.019_bib43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1155\/2011\/938794","article-title":"Prognostic values of serum IP-10 and IL-17 in patients with pulmonary tuberculosis","volume":"31","author":"Chen","year":"2011","journal-title":"Dis Markers"},{"issue":"9","key":"10.1016\/j.jinf.2014.12.019_bib44","doi-asserted-by":"crossref","first-page":"e105628","DOI":"10.1371\/journal.pone.0105628","article-title":"Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots","volume":"9","author":"Blauenfeldt","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2014.12.019_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-0928-5_3","article-title":"ELISA-based assay for IP-10 detection from filter paper samples","volume":"1172","author":"Drabe","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.jinf.2014.12.019_bib46","doi-asserted-by":"crossref","first-page":"e39228","DOI":"10.1371\/journal.pone.0039228","article-title":"A simple method to quantitate IP-10 in dried blood and plasma spots","volume":"7","author":"Aabye","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jinf.2014.12.019_bib47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1183\/09031936.00129412","article-title":"Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper","volume":"42","author":"Aabye","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2014.12.019_bib48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/1471-2334-10-333","article-title":"IP-10 detection in urine is associated with lung diseases","volume":"10","author":"Cannas","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2014.12.019_bib49","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jinf.2014.02.008","article-title":"High urine IP-10 levels associate with chronic HCV infection","volume":"68","author":"Petrone","year":"2014","journal-title":"J Infect"},{"issue":"10","key":"10.1016\/j.jinf.2014.12.019_bib50","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(08)70227-5","article-title":"Tumour necrosis factor antagonists: structure, function, and tuberculosis risks","volume":"8","author":"Wallis","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2014.12.019_bib51","doi-asserted-by":"crossref","first-page":"e51338","DOI":"10.1371\/journal.pone.0051338","article-title":"Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"4 Pt 1","key":"10.1016\/j.jinf.2014.12.019_bib52","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1164\/ajrccm.157.4.9709126","article-title":"Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis","volume":"157","author":"Juffermans","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl. 2","key":"10.1016\/j.jinf.2014.12.019_bib53","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0264-410X(03)00199-3","article-title":"Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity","volume":"21","author":"Mantovani","year":"2003","journal-title":"Vaccine"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445315000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445315000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:20:55Z","timestamp":1759008055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445315000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0163445315000262"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2014.12.019","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2014.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}